Caries Risk Assesment and Caries Vaccine: K.Santoshi Mds Ii
Caries Risk Assesment and Caries Vaccine: K.Santoshi Mds Ii
Caries Risk Assesment and Caries Vaccine: K.Santoshi Mds Ii
K.SANTOSHI
K.SANTOSHI
MDS
MDS II
II
CONTENTS
CARIES RISK ASSESMENT
Introduction
Caries imbalance
Objectives
Caries risk models
Caries assesment tool
Caries management by risk assesment
Cariogram
Traffic light matrix
Caries risk factors
Caries risk indicator
Test in caries risk assesment
Caries activity test
Use of Caries risk assesment
CARIES VACCINE
Introduction
Immunity
Types of immune response
Requirements of caries vaccine
Streptococcus mutans
Antigenic components of streptococcus mutans
Mechanism of action of caries vaccine
Routes of immunization
Adjuvants and delivery systems
Recent advances
Risks
Limitation
Conclusion
refferences
INTRODUCTION
Procedure to predict
future caries
development before
the clinical onset of
the disease
Risk Factor
Is an environmental, behavioral, biologic or lifestyle exposure or characteristic
that increases the probability of a disease occurring
(Beck 1998)
Risk
Risk Indicator/Predictor/
Indicator/Predictor/ Marker
Marker
Biologic
Biologic marker
marker that
that is
is indicative
indicative of
of the
the disease
disease process,
process, but
but itit is
is not
not thought
thought to
to be
be
etiological
etiological for
for that
that disease.(
disease.( Beck
Beck et
et al
al .,., 1992)
1992)
Caries balance and imbalance concept Protective
Protective factors:
factors:
•Saliva
•Saliva &
& sealants
sealants
Risk
Risk Factors
Factors •Antibacterial
•Antibacterial
•Bad
•Bad bacteria
bacteria •Fluorides
Disease
Disease indicators:
indicators: •Fluorides
•Absence
•Absence of
of saliva
saliva •Effective
•White
•White spots
spots •Effective diet
diet
•Dietary
•Dietary
•Restorations
•Restorations >3
>3 yy habits(poor)
habits(poor)
•Enamel
•Enamel lesions
lesions
•Cavities/
•Cavities/ dentin
dentin
Treatment of the
disease process Anticipates caries
instead of treating the progression or
outcome of the stabilization
disease.
Individualizes,
selects, and Gives an
determines frequency understanding of the
of preventive and disease factors for a
restorative treatment specific patient.
for a patient.
Environmental Optimal systemic topical fluoride Suboptimal systemic fluoride Suboptimal topical fluoride
Characteristics exposure exposure with optimal topical exposure
Consumption of simple sugars or exposure Frequent (i.e. 3 or more) between-
foods strongly associated with Occasional (1-2) between-meal meal exposures to simple sugars or
caries initiation primarily at exposures to simple sugars or foods strongly associated with
mealtimes foods strongly associated with caries
High caregiver socioeconomic caries Low-level caregiver socioeconomic
status Mid-level caregiver socioeconomic status (i.e. Eligible for Medicaid)
Regular use of dental care in an status (i.e., eligible for school lunch No usual source of dental care
established dental home program or SCHIP) Active caries present in the mother
Irregular use of dental services
• The objective is to alert the clinician regarding the current risk status.
• This color code model keeps the visual interpretation simple and
communicable to the patient as well.
a) Resting: hydration, viscosity and pH
Saliva: b) Stimulated: quantity/rate, pH and buffering
capacity
:
Modifying factors
drugs that reduce salivary flow, diseases resulting in dry mouth, fixed/removable
appliances, recent active caries and poor compliance
The system scores Red, yellow & green light for each risk factors
depending on predetermined criteria.
• Tests are carried for each risk factors independently and scores
are generated.
• Saliva is then mixed with a buffer solution and 1 ml of the dilutions 10-2 and
10-3
53
SWAB TEST
No collection of saliva.
54
RESULTS
pH Caries activity
4.1 Marked caries activity
4.2-4.4 Active
4.5-4.6 Slightly active
Over 4.6 Caries in active
55
Dentobuff test /salivary buffer capacity
test
Principle : the test measures the number of milliliters of
acid required to lower the pH of saliva, from pH 7.0to 6.0
Equipment:
Ph meter
Titration equipment
0.05N lactic acid
0.05 N base
Paraffin
Sterile glass jars
56
5 ml of stimulated saliva collected
Identify
target
Should not
harm
host
it shoul be able
toIdentify
component of
immune system
that should be
stimulated/induced
Streptococcus Mutans
S. mutans
WHAT?
Gram +ve S.Sobrinus
Facultative S.Ratti
Anaerobe S.Criceti
8 serotypes S.Downei
Type h most S.Ferus
prevalent S.macacae
Acquisition of S.mutans
ADHESINES
identifi ed as antigens I/
II, Pac, or P1 and Streptococcus sobrinus, Spa-A or Pag)
GLUCOSYL
TRANSFERASE
GLUCAN BINDING
PROTEIN
DEXTRAN
Mechanism of action of caries vaccine
sIg
Inactivate GTF
Reduce glucans, plaque
Bacterial surface
receptors
Routes of immunisation
Oral/mucosal
Systemic(subcutaneous)
Colorectal region as an
inductive location for
mucosal immune responses
in humans
it has the highest
concentration of lymphoid
follicles in the lower
intestinal tract
Systemic / subcutaneous
IgG,IgM IgA
IgG, IgA
Passive Immunization
Monoclonal antibodies
Egg- yolk antibodies
Transgenic plants:
Adjuvants & Delivery Systems
Heat labile
enterotoxins Microcapsules & Liposomes
(Cholera & E.coli) microparticles
Katz 1993
Fusing with
Synthetic peptides
salmonella
RECENT ADVANCES:
Recently, a vaccine has been discovered; a protein called
p1025.
This protein tricks S.mutans; into a belief that there are no
vacant sites on the tooth for it to attack.
The bacteria consists of a surface protein that adheres to
the enamel.
Researchers have found that p1025 mimics the protein of
the bacterium, occupying all docking sites.
Risk of using caries vaccine
.
Due to potential of S.mutans whole cells to induce
heart – reactive Antibody, the development of subunit
vaccine (AgI/II) for caries has been focused of intense
research interest.
Limitations
In order to make immunization against caries further
clinical trials should be aimed at establishing whether
the findings from animal experiments can be transferred
to humans.
Efficacy of caries vaccine is limited and is of short
duration and further studies are required to evaluate the
efficacy
Limited research has been done in humans and most of
these studies were conducted in the early years and
showed only short‐term protection.
Conclusion
CARIES VACCINE
Caries vaccine definitely has a role to do in the future as it interferes
with the metabolism of the major etiological agent.
Integrating the caries vaccine after its development into public health
programs could be beneficial in bring dental caries to a minimal level.
references
Young DA, Fontana M, Wolff MS. Current concepts in
cariology. Dent Clin North Am 2010;54:479-493.